TY  - GEN
AU  - Kon,O M
AU  - Sihra,B S
AU  - Compton,C H
AU  - Leonard,T B
AU  - Kay,A B
AU  - Barnes,N C
TI  - Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma
SN  - 0140-6736
PY  - 1998///1117
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Asthma
KW  - drug therapy
KW  - CD4 Antigens
KW  - immunology
KW  - CD4-Positive T-Lymphocytes
KW  - drug effects
KW  - Chronic Disease
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Lymphocyte Count
KW  - Male
KW  - Middle Aged
KW  - Respiratory Function Tests
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S0140-6736(97)12261-9
ER  -